The application of cancer stem cell model in malignant mesothelioma
G Bronte, AD Procopio, L Graciotti - Critical Reviews in Oncology …, 2022 - Elsevier
The high mortality rate of malignant pleural mesothelioma led to study the mechanisms for
chemoresistance. The cancer stem cell (CSC) model has been proposed to explain …
chemoresistance. The cancer stem cell (CSC) model has been proposed to explain …
A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma
Recent advances in the management of diffuse pleural mesothelioma (DPM) have
increased interest in prognostication and risk stratification on the basis that maximum benefit …
increased interest in prognostication and risk stratification on the basis that maximum benefit …
Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant …
S Bongiolatti, F Mazzoni, O Salimbene… - Journal of Clinical …, 2021 - mdpi.com
Malignant pleural mesothelioma (MPM) is an aggressive disease with poor prognosis and
the current treatment for early-stage MPM is based on a multimodality therapy regimen …
the current treatment for early-stage MPM is based on a multimodality therapy regimen …
Survival analysis and development of a prognostic nomogram for patients with malignant mesothelioma in different anatomic sites
S Shao, L Sun, K Qin, X Jin, T Yi, Y Liu… - Frontiers in …, 2022 - frontiersin.org
Background Malignant mesothelioma (MMe) is a rare and fatal cancer with a poor
prognosis. Our study aimed to compare the overall survival (OS) of MMe patients across …
prognosis. Our study aimed to compare the overall survival (OS) of MMe patients across …
Feasibility of tumor treating fields with pemetrexed and platinum-based chemotherapy for unresectable malignant pleural mesothelioma: Single-center, real-world data
T Kutuk, H Appel, MC Avendano, F Albrecht, P Kaywin… - Cancers, 2022 - mdpi.com
Simple Summary Management of malignant pleural mesothelioma (MPM) is challenging as
patients frequently present with unresectable disease and the response rates with systemic …
patients frequently present with unresectable disease and the response rates with systemic …
Malignant mesothelioma
DL Pouliquen, J Kopecka - Cancers, 2021 - mdpi.com
Malignant mesothelioma (MM) is a rare and aggressive cancer, related to chronic
inflammation and oxidative stress caused mainly by exposure to asbestos. Although this …
inflammation and oxidative stress caused mainly by exposure to asbestos. Although this …
[HTML][HTML] Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man
AM Ibnian, OU Khan, R Chan… - The American Journal …, 2023 - ncbi.nlm.nih.gov
Objective: Unusual clinical course Background: Gelatinous pleural effusion, due to raised
hyaluronic acid, can be associated with pleural infection and malignancies, such as …
hyaluronic acid, can be associated with pleural infection and malignancies, such as …
A practical nomogram and risk stratification system predicting the cancer-specific survival for patients aged> 50 with advanced melanoma
Q Xi, X Lu, J Zhang, D Wang, Y Sun, H Chen - Frontiers in Oncology, 2023 - frontiersin.org
Objective To investigate risk factors for advanced melanoma over 50 years of age and to
develop and validate a new line chart and classification system. Methods The SEER …
develop and validate a new line chart and classification system. Methods The SEER …
[PDF][PDF] ALLEY PROOF
AS Chen - Med Sci Monit, 2020 - pdfs.semanticscholar.org
Background: Aminoacylase 1 (ACY-1) is a cytosolic enzyme that catalyzes amino acid
deacylation and has been reported to participate in various human diseases. However, the …
deacylation and has been reported to participate in various human diseases. However, the …